Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective-Reference-Cited by-同舟云学术

Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective

Published:2008 Issue:1 Volume:6 Page:13
ISSN:1477-7525
Container-title:Health and Quality of Life Outcomes
language:en
Short-container-title:Health and Quality of Life Outcomes

Author:

Mathias Susan D,Gao Sue K,Miller Kimberly L,Cella David,Snyder Claire,Turner Ralph,Wu Albert,Bussel James B,George James N,McMillan Robert,Wysocki Diane,Nichol Janet L

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,General Medicine

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Primary Immune Thrombocytopenia During Pregnancy: Management Strategies and Considerations: A Comprehensive Review;Cureus;2024-08-20

2. Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study;The Lancet Haematology;2024-08

4. Risk of fractures and use of bisphosphonates in adult patients with immune thrombocytopenia—A nationwide population‐based study;British Journal of Haematology;2024-02

5. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial;The Lancet;2023-11